Fructose-2,6-bisphosphate in control of hepatic gluconeogenesis. From metabolites to molecular genetics
- PMID: 2162755
- DOI: 10.2337/diacare.13.6.582
Fructose-2,6-bisphosphate in control of hepatic gluconeogenesis. From metabolites to molecular genetics
Erratum in
- Diabetes Care 1990 Oct;13(10):1098
Abstract
Hormonal regulation of hepatic gluconeogenic pathway flux is brought about by phosphorylation/dephosphorylation and control of gene expression of several key regulatory enzymes. Regulation by cAMP-dependent phosphorylation occurs at the level of pyruvate kinase and 6-phosphofructo-2-kinase (6PF-1-K)/fructose-2,6-bisphosphatase (Fru-2,6-P2ase). The latter is a unique bifunctional enzyme that catalyzes both the synthesis and degradation of fructose-2,6-bisphosphate (Fru-2,6-P2), which is an activator of 6PF-1-K and an inhibitor of Fru-1,6-P2ase. The bifunctional enzyme is a homodimer whose activities are regulated by cAMP-dependent protein kinase-catalyzed phosphorylation at a single NH2-terminal seryl residue/subunit, which results in activation of the Fru-2,6-P2ase and inhibition of the PF-1-K reactions. Hormone-mediated changes in the phosphorylation state of the bifunctional enzyme are responsible for acute regulation of Fru-2,6-P2 levels. 6PF-2-K/Fru-2,6-P2ase thus provides a switching mechanism between glycolysis and gluconeogenesis in mammalian liver. Pyruvate kinase is regulated by both phosphorylation and allosteric effectors. Fru-1,6-P2, an allosteric activator, also inhibits cAMP-dependent enzyme phosphorylation, and its steady-state concentration is indirectly determined by the level of Fru-2,6-P2. Therefore, acute regulation of both pyruvate kinase and the bifunctional enzyme provide coordinated control at both the pyruvate/phosphoenolpyruvate and Fru-6-P/Fru-1,6-P2 substrate cycles. The Fru-2,6-P2 system is also subject to complex multihormonal long-term control through regulation of 6 PF-2-K/Fru-2,6-P2ase gene expression. Glucocorticoids are the major factor in turning on this gene in liver, but insulin is also a positive effector. cAMP prevents the effects of glucocorticoids and insulin. Although Fru-2,6-P2 plays a key role in the regulation of carbon flux in the gluconeogenic pathway, the regulation of this flux depends on several factors and regulation of other key enzymes whose importance varies depending on the dietary and hormonal status of the animal. Molecular cloning of the cDNA encoding PF-2-K/Fru-2,6-P2ase has elucidated its structure and permitted analysis of its evolutionary origin as well as its tissue distribution and control of its gene expression. The rat liver and skeletal muscle isoforms arose by alternative splicing of a single gene. The muscle form differs from the liver form only at the NH2-terminal and does not have a cAMP-dependent protein kinase phosphorylation site. The hepatic enzyme subunit consists of 470 amino acids.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Covalent control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: insights into autoregulation of a bifunctional enzyme.Protein Sci. 1995 Jun;4(6):1023-37. doi: 10.1002/pro.5560040601. Protein Sci. 1995. PMID: 7549867 Free PMC article. Review.
-
Activation of glycolysis by insulin with a sequential increase of the 6-phosphofructo-2-kinase activity, fructose-2,6-bisphosphate level and pyruvate kinase activity in cultured rat hepatocytes.Eur J Biochem. 1985 Dec 2;153(2):347-53. doi: 10.1111/j.1432-1033.1985.tb09309.x. Eur J Biochem. 1985. PMID: 3000776
-
Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.J Nutr. 1997 Jul;127(7):1274-8. doi: 10.1093/jn/127.7.1274. J Nutr. 1997. PMID: 9202079
-
Tolbutamide inhibits glucagon-induced phosphorylation of 6PF-2-K/Fru-2,6-P2ase in rat hepatocytes.Am J Physiol. 1995 Mar;268(3 Pt 1):E391-6. doi: 10.1152/ajpendo.1995.268.3.E391. Am J Physiol. 1995. PMID: 7900785
-
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.Annu Rev Physiol. 1992;54:885-909. doi: 10.1146/annurev.ph.54.030192.004321. Annu Rev Physiol. 1992. PMID: 1562196 Review.
Cited by
-
Pathogenic role of PFKFB3 in endothelial inflammatory diseases.Front Mol Biosci. 2024 Sep 10;11:1454456. doi: 10.3389/fmolb.2024.1454456. eCollection 2024. Front Mol Biosci. 2024. PMID: 39318551 Free PMC article. Review.
-
Oxygen and Iron Availability Shapes Metabolic Adaptations of Cancer Cells.World J Oncol. 2024 Feb;15(1):28-37. doi: 10.14740/wjon1739. Epub 2024 Jan 10. World J Oncol. 2024. PMID: 38274726 Free PMC article. Review.
-
Metabolites as signalling molecules.Nat Rev Mol Cell Biol. 2023 May;24(5):355-374. doi: 10.1038/s41580-022-00572-w. Epub 2023 Jan 12. Nat Rev Mol Cell Biol. 2023. PMID: 36635456 Review.
-
Transcriptional profiling of skeletal muscle reveals starvation response and compensatory growth in Spinibarbus hollandi.BMC Genomics. 2019 Dec 5;20(1):938. doi: 10.1186/s12864-019-6345-2. BMC Genomics. 2019. PMID: 31805873 Free PMC article.
-
Targeting FBPase is an emerging novel approach for cancer therapy.Cancer Cell Int. 2018 Mar 9;18:36. doi: 10.1186/s12935-018-0533-z. eCollection 2018. Cancer Cell Int. 2018. PMID: 29556139 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
